Replacing TDF With TAF for HIV Tied to Adverse Metabolic Changes

FRIDAY, April 9, 2021 -- For people with HIV receiving tenofovir-based antiretroviral therapy (ART), replacing tenofovir disoproxil fumarate (TDF) with tenofovir alafenamide (TAF) is associated with adverse metabolic changes, including weight...

Source: Drugs.com - Pharma News - April 9, 2021 Category: Pharmaceuticals Source Type: news